UMB-20050-99692 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-27
Registered in v-safe
2020-12-27
Dose 1 — Moderna
2020-12-27
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-29
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-31
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-05
Health check-in — day 7, dose 1
Feeling: Good · Headache

Adult check-in
2021-01-10
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-20
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-01-24
Survey response — day 28, dose 1
MedDRA: Headache, Lethargy, Nausea, Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Congested, sneezing, runny nose, headache, lethargy, nausea.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-31
Dose 2 — Moderna
2021-01-31
Survey response — day 0, dose 2
MedDRA: Musculoskeletal stiffness — Feeling: Poor · Site: Pain, Redness, Swelling · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Stiffness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-06
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-23
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2022-02-02
Survey response — 12 months, dose 2
MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: COVID

MedDRA releases: 2024-11 · check-in free text available
2022-02-02
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-07
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-27	Moderna
2	2021-01-31	Moderna

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 2 — day 28, dose 1

2021-01-24

Symptoms: Congested, sneezing, runny nose, headache, lethargy, nausea.

Release 3 — day 0, dose 2

2021-01-31

Systemic reaction (other): Stiffness

Release 11 — 12 months, dose 2

2022-02-02

Symptoms: COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Headache	✓	✓	✓
SD	Lethargy	✓	✓	✓
SD	Nausea	✓	✓	✓
SD	Respiratory tract congestion	✓	✓	✓
SD	Rhinorrhoea	✓	✓	✓
SD	Sneezing	✓	✓	✓
SRO	Musculoskeletal stiffness	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release